Breast cancer is the most common malignant tumor globally as of 2020 and remains the
second leading cause of cancer-related death among female individuals worldwide …

Reprogramming of cellular metabolism is one of the hallmarks of breast cancer. Breast
cancer cells remodel metabolic network to maintain their transformed state and survive in a …

Metabolic reprogramming is an emerging hallmark of breast cancer. A common
characteristic of tumor cells is the ability to obtain nutrients from a nutrient-deprived …

Breast cancer (BC) is a malignant tumor that seriously endangers health in women. BC, like
other cancers, is accompanied by metabolic reprogramming. Among energy metabolism …

Simple Summary Breast cancer comprises a wide variety of cancer cells that present distinct
phenotypes and develop various nutrient dependencies to grow and survive in stressful …

Metabolomics, the study of metabolites and small intermediate molecules, may play a key
role in further elucidation of breast cancer. This dynamic, simultaneous assessment of …

Current standard-of-care (SOC) therapy for breast cancer includes targeted therapies such
as endocrine therapy for estrogen receptor-alpha (ERα) positive; anti-HER2 monoclonal …

Metabolic reprogramming, an emerging hallmark of cancer, is observed in breast cancer.
Breast cancer cells rewire their cellular metabolism to meet the demands of survival …

The metabolic properties of cancer cells significantly differ from those of normal cells. In
particular, cancer cells are largely dependent on aerobic glycolysis, a phenomenon that has …

Altered metabolism in tumor cells has been a focus of cancer research for as long as a
century but has remained controversial and vague due to an inhomogeneous overall …